Cargando…
Retracted: NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533239/ https://www.ncbi.nlm.nih.gov/pubmed/37772002 http://dx.doi.org/10.1155/2023/9820474 |
| _version_ | 1785112148486127616 |
|---|---|
| author | Healthcare Engineering, Journal of |
| author_facet | Healthcare Engineering, Journal of |
| author_sort | Healthcare Engineering, Journal of |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10533239 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105332392023-09-28 Retracted: NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641 Healthcare Engineering, Journal of J Healthc Eng Retraction Hindawi 2023-09-20 /pmc/articles/PMC10533239/ /pubmed/37772002 http://dx.doi.org/10.1155/2023/9820474 Text en Copyright © 2023 Journal of Healthcare Engineering. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction Healthcare Engineering, Journal of Retracted: NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641 |
| title | Retracted: NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641 |
| title_full | Retracted: NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641 |
| title_fullStr | Retracted: NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641 |
| title_full_unstemmed | Retracted: NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641 |
| title_short | Retracted: NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641 |
| title_sort | retracted: nr2f1-as1 acts as an oncogene in breast cancer by competitively binding with mir-641 |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533239/ https://www.ncbi.nlm.nih.gov/pubmed/37772002 http://dx.doi.org/10.1155/2023/9820474 |
| work_keys_str_mv | AT healthcareengineeringjournalof retractednr2f1as1actsasanoncogeneinbreastcancerbycompetitivelybindingwithmir641 |